An observational study in Rib Fracture and Rib Fracture Multiple, sponsored by Zimmer Biomet. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-21.
Sponsored by Zimmer Biomet · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Rib Fractures with a site in United States — 9 open to participants now, 10 under way, none of them phase 3. Rib Fractures · United States.
Among the 48 studies in Rib Fractures with a site in United States, this one is the only one that started in 2026, is one of 7 observational ones, and was the 48th registered.
126 studies on the registry are indexed under Rib Fractures; 28 are open to participants now.
Browse Rib Fractures studies →9 of the 48 studies in Rib Fractures with a site in United States are open now. Recruiting first, the newest first:
Zachary Warriner · Sites in United States
Ages 18+
Albert Einstein College of Medicine · Sites in United States
Ages 18+
University of Minnesota · Sites in United States
Ages 18+
Loma Linda University · Sites in United States
Ages 18–80 · Healthy volunteers
Brigham and Women's Hospital · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 14 Rib Fractures studies recruiting now, 9 (64%) set no upper age limit and 1 (7%) stops at 75 or younger; none take children under 18; 3 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 54 is below the median of 100 across 27 observational studies indexed under Rib Fractures.
Median enrollment 36 across the 41 interventional studies, 43 across the 7 observational. Of the 33 that completed or were terminated, 17 (52%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 48 have an industry lead sponsor. The 10 most frequent:
Zimmer Biomet is the lead sponsor of 275 studies on the registry; 28 are open to participants now.
Of its 22 completed or terminated interventional studies of FDA-regulated products, 19 (86%) have results posted.
Zimmer Biomet has 4 studies filed under Rib Fractures — fewer than ten, so there is no comparison to draw.
7 of the studies in Rib Fractures with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06538376Brigham and Women's HospitalClinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU | 2026-11 |
| NCT05642026Zachary WarrinerINTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures | 2027-02-01 |
| NCT06347874University of MinnesotaCryo Rib Fracture Study | 2027-02-13 |
| NCT05748366WellSpan HealthUltrasound Guided Serratus Anterior Plane Block for Rib Fractures | 2027-03-31 |
| NCT07032766Albert Einstein College of MedicineAssessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures | 2027-07 |
Add all 7 to your calendar (.ics) → With an account.
Among the 48 studies in Rib Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall including rib reconstructive surgical procedures, trauma, or planned osteotomies.
Consecutive patients who meet all of the inclusion criteria and none of the exclusion criteria will be eligible for participation in the study, and will be pre-screened for participation in the informed consent process.
The primary objective is the assessment of safety by analyzing reoperation rates related to the RibFix Titan™ at 90 days post-implantation. A reoperation will be considered any additional surgical procedure to revise, adjust, or replace the subject device's components and/or any surgical procedure to manage complications directly caused by the device.
This study is designed to evaluate safety parameters by recording the incidence and frequency of complications and adverse events. Relationship of the events to the implant, instrumentation, and/or procedure through the operative and post-operative follow-up periods shall be specified.
The secondary objectives include functional performance and clinical benefits by clinical evaluation of fracture/osteotomy union and patient reported outcome measures (PROMs). This study will also measure resource utilization in subjects with RibFix Titan™, including intensive care unit (ICU) length of stay, hospital length of stay, and operative time.
Data collection will occur at the following intervals: Pre-operative, Operative, 14-days, 45-days, 90-days, and 1-year post-operatively. Enrollment for the study is anticipated to last approximately 12 months. Allowing for 12 months of follow-up, the total estimated study time to final-patient final-visit will be approximately 24 months.
The study population will include subjects with rib fractures identified at the point of clinical presentation, including emergency departments, trauma centers, or outpatient healthcare settings.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Consecutive patients will undergo rib fixation procedure using the RibFix Titan fixation system.
Device: The RibFix Titan™ device should be used within this arm of the study.
Rib Fixation
Evaluation of Patient Safety
Assessment of safety by analyzing reoperation rates related to the RibFix Titan™ at 90 days post-implantation. A reoperation will be considered any additional surgical procedure to revise, adjust, or replace the subject device's components and/or any surgical procedure to manage complications directly caused by the device.
Time frame: 90 days
Patient Reported Outcome Measure (PROMIS-Pain Interference 8a)
8-item questionnaire, completed by the patient, with questions asking the patient to rate how much pain has impacted daily functioning over the past 7 days.
Time frame: 12 Months
Patient Reported Outcome Measure (PROMIS-Physical Function 10b)
10-item questionnaire, answered by the patient, with questions asking the patient to rate their level of difficulty performing physical activities.
Time frame: 12 Months
Patient Reported Outcome Measure (Numeric Pain Rating Scale)
1-item questionnaire asking the patient to rate their pain on average on a numeric scale, from 0 to 10 where 0 is No Pain and 10 is Worst Imaginable Pain.
Time frame: 12 Months
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Jul 2027, 16 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.